Cardinal Health Inc (CAH) stock
CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3042% above fair value
$278.32−0.93 (-0.33%)
Close on Nov 18, 2026Market cap $64.73BP/E 38.5Yield 0.73%
Cardinal Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cardinal Health's operating income for the twelve months ending Jun 30, 2026 was $2.61B, up 14.9% year over year. For fiscal 2026 it was $2.61B, up 14.9% from the year before. Over ten years it grew 0.6% a year on average. The highest annual figure on record is $2.61B in fiscal 2026.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $2.61B | +14.9% |
| FY2025 | Jun 30, 2025 | $2.28B | +83.0% |
| FY2024 | Jun 30, 2024 | $1.24B | +65.3% |
| FY2023 | Jun 30, 2023 | $752.00M | – |
| FY2022 | Jun 30, 2022 | -$607.00M | -228.6% |
| FY2021 | Jun 30, 2021 | $472.00M | – |
| FY2020 | Jun 30, 2020 | -$4.10B | -298.9% |
| FY2019 | Jun 30, 2019 | $2.06B | +1534.9% |
| FY2018 | Jun 30, 2018 | $126.00M | -94.1% |
| FY2017 | Jun 30, 2017 | $2.12B | -13.8% |
| FY2016 | Jun 30, 2016 | $2.46B | +13.8% |
| FY2015 | Jun 30, 2015 | $2.16B | +14.6% |
| FY2014 | Jun 30, 2014 | $1.89B | +89.3% |
| FY2013 | Jun 30, 2013 | $996.00M | -44.4% |
| FY2012 | Jun 30, 2012 | $1.79B | +18.4% |
| FY2011 | Jun 30, 2011 | $1.51B | +15.8% |
| FY2010 | Jun 30, 2010 | $1.31B | +1.5% |
| FY2009 | Jun 30, 2009 | $1.29B | -7.5% |
| FY2008 | Jun 30, 2008 | $1.39B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $729.00M | +70.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $509.00M | -30.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $707.00M | +28.8% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $668.00M | +17.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $428.00M | +6.7% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $730.00M | +97.8% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $549.00M | +8.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $568.00M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $401.00M | +147.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $369.00M | -38.9% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $505.00M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$32.00M | -126.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $162.00M | +548.0% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $604.00M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$86.00M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $123.00M | -70.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $25.00M | -84.6% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$97.00M | -120.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$950.00M | -306.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $415.00M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $162.00M | -40.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $473.00M | -15.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $461.00M | +38.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$624.00M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $270.00M | -12.3% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $562.00M | +30.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $334.00M | -33.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$5.26B | -745.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $308.00M | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $432.00M | -20.9% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $504.00M | +26.3% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $816.00M | +211.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$1.08B | -346.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $546.00M | -9.8% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $399.00M | -26.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $262.00M | -51.0% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $439.00M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $605.00M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $542.00M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $535.00M | – |
See a number that looks wrong?